Stock Earnings CNTX shares expected to outperform in the next 12 months The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Analysts Viewpoint Context Therapeutics Inc [CNTX] Investment Appeal on the Rise Context Therapeutics Inc’s recently made public that its Chief Executive Officer Lehr Martin A. acquired Company’s shares for reported $70080.0